Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Sulfur (S VI) based moieties, especially, the sulfonyl or sulfonamide based analogues have
showed a variety of pharmacological properties, and its derivatives propose a high degree …
showed a variety of pharmacological properties, and its derivatives propose a high degree …
Kinin B1 receptors as a therapeutic target for inflammation
F Qadri, M Bader - Expert opinion on therapeutic targets, 2018 - Taylor & Francis
Introduction: Kinins are peptide mediators exerting their pro-inflammatory actions by the
selective stimulation of two distinct G-protein coupled receptors, termed BKB1R and BKB2R …
selective stimulation of two distinct G-protein coupled receptors, termed BKB1R and BKB2R …
Divergent Synthesis of Multi‐Substituted Aminotetralins via [4+2] Annulation of Aldimines with Alkenes by Rare‐Earth‐Catalyzed Benzylic C(sp3)−H Activation
The search for efficient and selective methods for the divergent synthesis of multi‐substituted
aminotetralins is of much interest and importance. We report herein for the first time the …
aminotetralins is of much interest and importance. We report herein for the first time the …
Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control
Y Wang, A Kirschner, AK Fabian… - Journal of medicinal …, 2013 - ACS Publications
The design of efficient ligands remains a key challenge in drug discovery. In the quest for
lead-like ligands for the FK506-binding protein 51 (FKBP51), we designed two new classes …
lead-like ligands for the FK506-binding protein 51 (FKBP51), we designed two new classes …
Conformational restriction and/or steric hindrance in medicinal chemistry
A Mann - The practice of medicinal chemistry, 2008 - Elsevier
Publisher Summary The understanding of the thermodynamics of the events that are
governing molecular recognition is essential for the practice of medicinal chemistry. This …
governing molecular recognition is essential for the practice of medicinal chemistry. This …
Bombesin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
J Battey, RV Benya, RT Jensen… - IUPHAR/BPS Guide to …, 2019 - journals.ed.ac.uk
Mammalian bombesin (Bn) receptors comprise 3 subtypes: BB 1, BB 2, BB 3 (nomenclature
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[109]). BB 1 and …
recommended by the NC-IUPHAR Subcommittee on bombesin receptors,[109]). BB 1 and …
Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists
JJ Chen, W Qian, K Biswas, VN Viswanadhan… - Bioorganic & medicinal …, 2008 - Elsevier
Replacement of the core β-amino acid in our previously reported piperidine acetic acid and
β-phenylalanine-based Bradykinin B1 antagonists by dihydroquinoxalinone acetic acid …
β-phenylalanine-based Bradykinin B1 antagonists by dihydroquinoxalinone acetic acid …
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain
H Huang, MR Player - Journal of medicinal chemistry, 2010 - ACS Publications
The Kinin Family. Kinins are naturally occurring vasoactive peptide hormones, which are
known to be important mediators of a variety of biological effects, including cardiovascular …
known to be important mediators of a variety of biological effects, including cardiovascular …
Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists
K Biswas, TAN Peterkin, MC Bryan, L Arik… - Journal of medicinal …, 2011 - ACS Publications
The bradykinin B1 receptor is rapidly induced upon tissue injury and inflammation,
stimulating the production of inflammatory mediators resulting in plasma extravasation …
stimulating the production of inflammatory mediators resulting in plasma extravasation …
Bradykinin receptor antagonists–a review of the patent literature 2005–2008
CI Fincham, A Bressan, M Paris, C Rossi… - Expert opinion on …, 2009 - Taylor & Francis
Background: For> 20 years, pharmaceutical companies and academic centers have been
developing bradykinin antagonists. The patent literature on these molecules (up to and …
developing bradykinin antagonists. The patent literature on these molecules (up to and …